BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17949684)

  • 1. p53-dependent change in replication timing of the human genome.
    Watanabe Y; Shibata K; Sugimura H; Maekawa M
    Biochem Biophys Res Commun; 2007 Dec; 364(2):289-93. PubMed ID: 17949684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification through microarray gene expression analysis of cellular responses to benzo(a)pyrene and its diol-epoxide that are dependent or independent of p53.
    Hockley SL; Arlt VM; Jahnke G; Hartwig A; Giddings I; Phillips DH
    Carcinogenesis; 2008 Jan; 29(1):202-10. PubMed ID: 17942461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control.
    Willers H; McCarthy EE; Wu B; Wunsch H; Tang W; Taghian DG; Xia F; Powell SN
    Oncogene; 2000 Feb; 19(5):632-9. PubMed ID: 10698508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor participates in multiple cell cycle checkpoints.
    Giono LE; Manfredi JJ
    J Cell Physiol; 2006 Oct; 209(1):13-20. PubMed ID: 16741928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication timing of the human genome.
    Woodfine K; Fiegler H; Beare DM; Collins JE; McCann OT; Young BD; Debernardi S; Mott R; Dunham I; Carter NP
    Hum Mol Genet; 2004 Jan; 13(2):191-202. PubMed ID: 14645202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis by R-flurbiprofen in human colon carcinoma cells: involvement of p53.
    Grösch S; Schilling K; Janssen A; Maier TJ; Niederberger E; Geisslinger G
    Biochem Pharmacol; 2005 Mar; 69(5):831-9. PubMed ID: 15710360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ckap2 regulates aneuploidy, cell cycling, and cell death in a p53-dependent manner.
    Tsuchihara K; Lapin V; Bakal C; Okada H; Brown L; Hirota-Tsuchihara M; Zaugg K; Ho A; Itie-Youten A; Harris-Brandts M; Rottapel R; Richardson CD; Benchimol S; Mak TW
    Cancer Res; 2005 Aug; 65(15):6685-91. PubMed ID: 16061649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis.
    Liu T; Laurell C; Selivanova G; Lundeberg J; Nilsson P; Wiman KG
    Cell Death Differ; 2007 Mar; 14(3):411-21. PubMed ID: 16917513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells.
    Hill R; Leidal AM; Madureira PA; Gillis LD; Cochrane HK; Waisman DM; Chiu A; Lee PW
    DNA Repair (Amst); 2008 Feb; 7(2):239-52. PubMed ID: 18024214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused PCR screen reveals p53 dependence of nitric oxide-induced apoptosis and up-regulation of maspin and plasminogen activator inhibitor-1 in tumor cells.
    Lim S; Hung AC; Porter AG
    Mol Cancer Res; 2009 Jan; 7(1):55-66. PubMed ID: 19147537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
    Zopf S; Neureiter D; Bouralexis S; Abt T; Glaser KB; Okamoto K; Ganslmayer M; Hahn EG; Herold C; Ocker M
    Int J Oncol; 2007 Dec; 31(6):1391-402. PubMed ID: 17982666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A global map of p53 transcription-factor binding sites in the human genome.
    Wei CL; Wu Q; Vega VB; Chiu KP; Ng P; Zhang T; Shahab A; Yong HC; Fu Y; Weng Z; Liu J; Zhao XD; Chew JL; Lee YL; Kuznetsov VA; Sung WK; Miller LD; Lim B; Liu ET; Yu Q; Ng HH; Ruan Y
    Cell; 2006 Jan; 124(1):207-19. PubMed ID: 16413492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication timing of extremely large genes on human chromosomes 11q and 21q.
    Watanabe Y; Shibata K; Ikemura T; Maekawa M
    Gene; 2008 Sep; 421(1-2):74-80. PubMed ID: 18620035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between replication timing and GC content of cancer-related genes on human chromosomes 11q and 21q.
    Watanabe Y; Abe T; Ikemura T; Maekawa M
    Gene; 2009 Mar; 433(1-2):26-31. PubMed ID: 19124063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
    Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
    Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.